InVitria (Ventria Bioscience)
Is this your company? Claim this profile
Excipients & Specialty Ingredients
Company Overview
About
InVitria (Ventria Bioscience) is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Quality Control, Stability Testing, Method Development
Therapeutic Areas
Neurology
Quick Facts
HQ:United States
Founded:2014
Employees:1,792
Capabilities & Services
Core Capabilities
- Cytotoxic / ADC Handling
- High-Potency API
- Sterile Fill/Finish
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Topical / Transdermal
Containment Capabilities
OEB 4 (1-10 µg/m³)
Production Scales
Phase II
Clinical
Pilot Scale
Markets Served
Global
Regulatory Approvals
Drug Approval ZDPHDY
PMDA · #APR-5NH3361N · 2019-02-01
Drug Approval 2X4RTM
Health Canada · #APR-R8RSNMFI · 2021-02-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-JZ6H63X0
Issued: 2020-10-17
Expires: 2025-02-18
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-9A2IPL2V
Issued: 2020-03-19
Expires: 2025-11-13
ISO 9001:2015
International Organization for Standardization
Cert #: CERT-EV2RDF46
Issued: 2020-06-12
Expires: 2025-06-03
Loading CDMO intelligence...
Key facts about InVitria (Ventria Bioscience)
- InVitria (Ventria Bioscience) is headquartered in the United States.
- InVitria (Ventria Bioscience) was founded in 2014.
- InVitria (Ventria Bioscience) has 1,792 employees.
- InVitria (Ventria Bioscience)'s capabilities include Cytotoxic / ADC Handling, High-Potency API and Sterile Fill/Finish.
Find CDMOs like InVitria (Ventria Bioscience)
Directory pages this company appears in, each with the full list of matching manufacturers.